A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH
Status:
Completed
Trial end date:
2019-03-19
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the efficacy and safety of tolvaptan based on
the change in serum sodium concentration following administration of tolvaptan oral tablets
at 7.5 to 60 mg/day for up to 30 days in patients with hyponatremia in the SIADH.